Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

MD Bronstein; M Fleseriu; S.J.C.M.M. Neggers; A Colao; M Sheppard; F Gu; CC Shen; M Gadelha; AJ Farrall; KH Resendiz; M Ruffin; Y M Chen; P Freda

doi:10.1186/s12902-016-0096-8

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

MD Bronstein
, M Fleseriu
, S.J.C.M.M. Neggers
, A Colao
, M Sheppard
, F Gu
, CC Shen
, M Gadelha
, AJ Farrall
, KH Resendiz
, M Ruffin
, Y M Chen
, P Freda

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

76 Citations (Scopus)

55 Downloads (Pure)

Original language	Undefined/Unknown
Article number	16
Journal	BMC Endocrine Disorders
Volume	16
DOIs	https://doi.org/10.1186/s12902-016-0096-8
Publication status	Published - 2016

Research programs

EMC MM-01-39-04

Access to Document

10.1186/s12902-016-0096-8

document.pdfFinal published version, 726 KB

Cite this

Bronstein, MD., Fleseriu, M., Neggers, S. J. C. M. M., Colao, A., Sheppard, M., Gu, F., Shen, CC., Gadelha, M., Farrall, AJ., Resendiz, KH., Ruffin, M., Chen, Y. M., & Freda, P. (2016). Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study. BMC Endocrine Disorders, 16, Article 16. https://doi.org/10.1186/s12902-016-0096-8

@article{dda4017820a342b8b0d7385941e8576c,

title = "Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study",

author = "MD Bronstein and M Fleseriu and S.J.C.M.M. Neggers and A Colao and M Sheppard and F Gu and CC Shen and M Gadelha and AJ Farrall and KH Resendiz and M Ruffin and Chen, \{Y M\} and P Freda",

year = "2016",

doi = "10.1186/s12902-016-0096-8",

language = "Undefined/Unknown",

volume = "16",

journal = "BMC Endocrine Disorders",

issn = "1472-6823",

publisher = "BioMed Central Ltd.",

}

Bronstein, MD, Fleseriu, M, Neggers, SJCMM, Colao, A, Sheppard, M, Gu, F, Shen, CC, Gadelha, M, Farrall, AJ, Resendiz, KH, Ruffin, M, Chen, YM & Freda, P 2016, 'Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study', BMC Endocrine Disorders, vol. 16, 16. https://doi.org/10.1186/s12902-016-0096-8

TY - JOUR

T1 - Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

AU - Bronstein, MD

AU - Fleseriu, M

AU - Neggers, S.J.C.M.M.

AU - Colao, A

AU - Sheppard, M

AU - Gu, F

AU - Shen, CC

AU - Gadelha, M

AU - Farrall, AJ

AU - Resendiz, KH

AU - Ruffin, M

AU - Chen, Y M

AU - Freda, P

PY - 2016

Y1 - 2016

U2 - 10.1186/s12902-016-0096-8

DO - 10.1186/s12902-016-0096-8

M3 - Article

C2 - 27039081

SN - 1472-6823

VL - 16

JO - BMC Endocrine Disorders

JF - BMC Endocrine Disorders

M1 - 16

ER -